At the EULAR 2025 Congress, researchers reported that GLP-1 receptor agonists were linked to reduced opioid use, pain, and fatigue in fibromyalgia patients based on a large real-world analysis.
A single psilocybin dose combined with therapy led to lasting reductions in depression and anxiety for cancer patients two years after treatment, according to new research.
A long-term study of older adults found that symptoms of depression and loneliness began increasing years before the onset of pain and remained elevated afterward, especially in people with lower income or education levels.
A newly published study showed that a metabolite of paracetamol can directly block sodium channels in peripheral pain-sensing neurons, helping reduce pain without acting on the brain.
A Phase I study of intrathecal resiniferatoxin in patients with advanced cancer pain shows promising reductions in pain and opioid use, with durable effects and manageable side effects.
A new clinical trial is investigating whether removing clots using a modified access point can better prevent post-thrombotic syndrome in patients with extensive deep vein thrombosis.
A large U.S. hospital database study found that postoperative urinary retention after knee replacement is rising and linked to complications, especially in older men and patients with certain health conditions.